Table 2.
Species | Venom/Protein Component | Mechanism | Cancer Cell Type/Tissue | Reference |
---|---|---|---|---|
Ophiophagus hannah | Crude venom | Cytotoxic activity on pancreatic cancer cells (EC50; 1.39 ng/mL), reduced migration activity, and induction of apoptosis in PaTu 8988t cells |
Patu 8988t | [45] |
Crude venom | Reduced tumor-cell-induced angiogenesis in vivo | Zebrafish embryos | [45] | |
L-amino acid oxidase (OH-LAAO) | Antiproliferative activity on murine melanoma, human fibrosarcoma, and murine epithelial cells | B16/F10, HT1080, and Balb/3T3 | [30] | |
OH-LAAO | Cytotoxic activity on human breast adenocarcinoma cells (EC50 0.05 µg/mL) and apoptosis induction | MCF-7 | [33] | |
OH-LAAO | Apoptosis induction and inhibition of prostate tumor growth | PC-3 xenograft in nude mice | [32] | |
OH-LAAO | Induced alteration of gene expression involved in cytotoxicity and apoptotic effects | MCF-7 | [31] | |
OH-LAAO | Modulation of proteins involved in stress response, ubiquitination, proteolysis, cell proliferation, and apoptosis | MCF-7 | [33] | |
Naja kaouthia | Crude venom | Cytotoxic activity on pancreatic cancer cells (EC50 1.42 ng/mL) | PaTu 8988t | [45] |
Crude venom | Venom at a nonlethal dose inhibited tumor-cell proliferation and showed cytotoxic activity and apoptosis induction in human lung cancer cells and leukemic cells | Ehrlich-ascites cells (EAC), U937, K562 | [47] | |
Cytotoxin CT3 | Histopathological changes in leukemia cells treated with CT3 | A549 and HL60 | [48] | |
Cardiotoxic–cytotoxic protein | Antiproliferative activity and apoptosis induction in human leukemic cells | U947 and K562 | [49] | |
kaotree (N. kouthia) and atroporin (Crotalus atrox) combination | Elevated cytotoxic activity in various human cancer cells | HBL-100, BT-20, ZR-75-1, HT-29, and Diji | [50] |